Chang Y, Hsieh MH, Ju PC, Chang CC, et al. Risk of depression with GLP-1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new-user, active-comparator cohort study. Diabetes Obes Metab 2025 Sep 29. doi: 10.1111/dom.70175.
PMID: 41017578